Roumen Nakov

1.1k citations
26 papers · 864 indexed · h-index 13
Topics
Neutropenia and Cancer Infections (13 papers)Blood disorders and treatments (10 papers)Biosimilars and Bioanalytical Methods (8 papers)

In The Last Decade

Roumen Nakov

25 papers receiving 823 citations

Peers

Roumen Nakov
Comparison fields: 5 of 79
  • Internal Medicine 364
  • Cardiology and Cardiovascular Medicine 338
  • Surgery 274
  • Oncology 193
  • Hematology 137
Replace M Samama with:
M Samama France
Daniel Lechner Austria
Enrico Boschetti Italy
Karin Strandberg Sweden
Hans‐Martin Otten Netherlands
Erica Romualdi Italy
Rhona Maclean United Kingdom
Pasquale Parise Italy
Bożena Sobkowicz Poland
Paula F. Ypma Netherlands
Roumen Nakov relative to M Samama France M Samama's profile →
Citations per field
00.5×5.8×
M Samama · 1×
Citations per year

Countries citing papers authored by Roumen Nakov

Since Specialization
Citations

This map shows the geographic impact of Roumen Nakov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roumen Nakov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roumen Nakov more than expected).

Fields of papers citing papers by Roumen Nakov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roumen Nakov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roumen Nakov. The network helps show where Roumen Nakov may publish in the future.

Co-authorship network of co-authors of Roumen Nakov

This figure shows the co-authorship network connecting the top 25 collaborators of Roumen Nakov. A scholar is included among the top collaborators of Roumen Nakov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roumen Nakov. Roumen Nakov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 43
3 1
4 8
5 5
6 32
7 27
8 1
9 65
10 9
11 5
12 10
13 93
14 136
15 147
16 149
17 14
18 1
19 11
20
[cAMP levels in human spermatozoa after exposure to methylxanthines].
0

About Roumen Nakov

Roumen Nakov is a scholar working on Internal Medicine, Oncology and Immunology, having authored 26 papers that have together received 864 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (13 papers), Blood disorders and treatments (10 papers) and Biosimilars and Bioanalytical Methods (8 papers). The work is most often cited by research in Internal Medicine (364 citations), Cardiology and Cardiovascular Medicine (338 citations) and Hematology (137 citations). Roumen Nakov has collaborated with scholars based in Germany, United States and Russia. Frequent co-authors include Michael R. Lassen, Lars C. Borris, Vijay V. Kakkar, H.K. Breddin, V. Hach-Wunderle, Egon Pfarr, Frank Misselwitz, Rupert Bauersachs, Edelgard Lindhoff‐Last and Nadia Harbeck. Their work appears in journals such as New England Journal of Medicine, Blood and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026